| Message: | Faslodex Fulvestran 129453-61-8 Anti-Estrogen Steroids Anabolic Powder
Synonyms: ICI 182,780;FULVESTRANT;FULVESTRANT-13C1-D2;FASLODEX;(7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;7A,17B-[9[(4,4,5,5,5-PENTAFLUOROPENTYL)SULFINYL]NONYL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL;(7alpha,17beta)-nonyl);estra-1,3,5(10)-triene-3,17-diol,7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)
CAS:129453-61-8
MF:C32H47F5O3S
MW:606.77
Product Categories:Intermediates & Fine Chemicals;Pharmaceuticals;Nuclear Receptors;Chiral Reagents;Steroids;Sulfur & Selenium Compounds;FASLODEX;Anti-cancer&immunity;Inhibitors
Mol File: 129453-61-8.mol
Chemical Properties: White Powder
2.Description
Faslodex, AstraZeneca is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.
Faslodex is a selective estrogen receptor down-regulator (SERD). Faslodexis indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. The dosing schedule for Faslodex remains under investigation in an attempt to optimize its effectiveness. |
my account
